BUZZ-Sera Prognostics falls on stock offering news

Sera Prognostics Inc's SERA.O down 7.6% in extended trading to $4.11 as it looks to raise equity

Salt Lake City-based women's health co commences offering comprising stock and pre-funded warrants without disclosing deal size

Co says plans to use net offering proceeds to expand commercial infrastructure in the U.S., accelerate preparations for expansion in the European Union, fund additional studies to increase adoption of its blood test to predict preterm birth risks, PreTRM, including a potential submission to U.S. FDA for broad approval

Jefferies, TD Cowen and William Blair jt bookrunners for offering, joined by RBC

Co has ~33.77 mln shares outstanding giving it a current market cap of ~$150 mln, per LSEG

SERA shares on Mon closed down 2% at $4.45, extending YTD decline to 45%